2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate

C93H104FN21O26 — CID 159029545

IUPAC2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate
SMILESCCOC(=O)c1cc2c(N)c(N)cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c(N)c([N+](=O)[O-])cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)N2CC(C)(F)C2)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)O)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)OC(C)(C)C)c1=O)CCC4
InChIInChI=1S/C21H22FN5O4.C21H24N4O5.C17H20N4O7.C17H16N4O5.C17H22N4O5/c1-3-31-20(30)13-7-12-17-14(26-6-4-5-15(26)24-17)8-23-18(12)27(19(13)29)9-16(28)25-10-21(2,22)11-25;1-5-29-20(28)13-9-12-17-14(24-8-6-7-15(24)23-17)10-22-18(12)25(19(13)27)11-16(26)30-21(2,3)4;1-5-27-16(24)10-6-9-13(18)11(21(25)26)7-19-14(9)20(15(10)23)8-12(22)28-17(2,3)4;1-2-26-17(25)10-6-9-14-11(20-5-3-4-12(20)19-14)7-18-15(9)21(16(10)24)8-13(22)23;1-5-25-16(24)10-6-9-13(19)11(18)7-20-14(9)21(15(10)23)8-12(22)26-17(2,3)4/h7-8H,3-6,9-11H2,1-2H3;9-10H,5-8,11H2,1-4H3;6-7H,5,8H2,1-4H3,(H2,18,19);6-7H,2-5,8H2,1H3,(H,22,23);6-7H,5,8,18H2,1-4H3,(H2,19,20)
InChIKeyJURZSXJUUWTCBC-UHFFFAOYSA-N
MW1950.97 g/mol
LogP7.09
Rot. Bonds21

About 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate

2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate (PubChem CID 159029545) has the molecular formula C93H104FN21O26 and a molecular weight of 1950.97 g/mol. Its IUPAC name is 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate.

Molecular Properties

Compound Name2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate
PubChem CID159029545
Molecular FormulaC93H104FN21O26
Molecular Weight1950.97 g/mol
Exact Mass1949.74
IUPAC Name2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate
SMILESCCOC(=O)c1cc2c(N)c(N)cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c(N)c([N+](=O)[O-])cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)N2CC(C)(F)C2)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)O)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)OC(C)(C)C)c1=O)CCC4
InChIInChI=1S/C21H22FN5O4.C21H24N4O5.C17H20N4O7.C17H16N4O5.C17H22N4O5/c1-3-31-20(30)13-7-12-17-14(26-6-4-5-15(26)24-17)8-23-18(12)27(19(13)29)9-16(28)25-10-21(2,22)11-25;1-5-29-20(28)13-9-12-17-14(24-8-6-7-15(24)23-17)10-22-18(12)25(19(13)27)11-16(26)30-21(2,3)4;1-5-27-16(24)10-6-9-13(18)11(21(25)26)7-19-14(9)20(15(10)23)8-12(22)28-17(2,3)4;1-2-26-17(25)10-6-9-14-11(20-5-3-4-12(20)19-14)7-18-15(9)21(16(10)24)8-13(22)23;1-5-25-16(24)10-6-9-13(19)11(18)7-20-14(9)21(15(10)23)8-12(22)26-17(2,3)4/h7-8H,3-6,9-11H2,1-2H3;9-10H,5-8,11H2,1-4H3;6-7H,5,8H2,1-4H3,(H2,18,19);6-7H,2-5,8H2,1H3,(H,22,23);6-7H,5,8,18H2,1-4H3,(H2,19,20)
InChIKeyJURZSXJUUWTCBC-UHFFFAOYSA-N
XLogP7.09
TPSA617.12 Ų
H-Bond Donors4
H-Bond Acceptors44
Rotatable Bonds21
Heavy Atoms141
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001950.97
LogP ≤ 57.09
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1044

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-2-methyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(ethylamino)-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate
CID 158794806
2-Bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxylate;ethyl 7-hydroxy-1,2-dimethyl-6,7-dihydroimidazo[4,5-c][1,8]naphthyridine-8-carboxylate;ethyl 2-hydroxy-5-(methylamino)-6-nitro-1,2-dihydro-1,8-naphthyridine-3-carboxylate;6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxylic acid
CID 161903252

Frequently Asked Questions

What is the IUPAC name of 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate?
The IUPAC name of 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate (CID 159029545) is 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate.
What is the SMILES notation for 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate?
The canonical SMILES for 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate is CCOC(=O)c1cc2c(N)c(N)cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c(N)c([N+](=O)[O-])cnc2n(CC(=O)OC(C)(C)C)c1=O.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)N2CC(C)(F)C2)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)O)c1=O)CCC4.CCOC(=O)c1cc2c3nc4n(c3cnc2n(CC(=O)OC(C)(C)C)c1=O)CCC4.
What is the InChIKey of 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate?
The InChIKey is JURZSXJUUWTCBC-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H22FN5O4.C21H24N4O5.C17H20N4O7.C17H16N4O5.C17H22N4O5/c1-3-31-20(30)13-7-12-17-14(26-6-4-5-15(26)24-17)8-23-18(12)27(19(13)29)9-16(28)25-10-21(2,22)11-25;1-5-29-20(28)13-9-12-17-14(24-8-6-7-15(24)23-17)10-22-18(12)25(19(13)27)11-16(26)30-21(2,3)4;1-5-27-16(24)10-6-9-13(18)11(21(25)26)7-19-14(9)20(15(10)23)8-12(22)28-17(2,3)4;1-2-26-17(25)10-6-9-14-11(20-5-3-4-12(20)19-14)7-18-15(9)21(16(10)24)8-13(22)23;1-5-25-16(24)10-6-9-13(19)11(18)7-20-14(9)21(15(10)23)8-12(22)26-17(2,3)4/h7-8H,3-6,9-11H2,1-2H3;9-10H,5-8,11H2,1-4H3;6-7H,5,8H2,1-4H3,(H2,18,19);6-7H,2-5,8H2,1H3,(H,22,23);6-7H,5,8,18H2,1-4H3,(H2,19,20).
What are the key properties of 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate?
2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate has a molecular weight of 1950.97 g/mol, XLogP of 7.09, 21 rotatable bonds, 4 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-ethoxycarbonyl-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaen-6-yl)acetic acid;ethyl 5-amino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5,6-diamino-1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate;ethyl 6-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxylate is sourced from PubChem (CID 159029545), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).